Drs Camidge and Eisen discuss Dr Eisen's dual career in academia and industry, the importance of aligning academic and clinical strengths, and how industry experience can enhance drug development.
Tim Eisen, MB BChir, PhD
Advertisement
Articles by Tim Eisen, MB BChir, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on OncLive
1
FDA Approves Daratumumab and Hyaluronidase Plus VRd for Newly Diagnosed Multiple Myeloma
2
NP-G1-044 Receives FDA Orphan Drug Designation for Pancreatic Cancer
3
PD-L1 Expression Is More Predictive of Response to Pembrolizumab on Metastatic Sites in High-Grade Serous Ovarian Cancer
4
Ixazomib-Based Regimens Expand Options in Relapsed/Refractory Multiple Myeloma
5